OTCGREY
HLNCF

Haleon plc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Haleon plc Stock Price

Vitals

Today's Low:
$4.01
Today's High:
$4.01
Open Price:
$4.01
52W Low:
$0.0021
52W High:
$4.9719
Prev. Close:
$3.975
Volume:
250

Company Statistics

Market Cap.:
$37.85 billion
Book Value:
1.781
Revenue TTM:
$11.41 billion
Operating Margin TTM:
21.92%
Gross Profit TTM:
$6.74 billion
Profit Margin:
10.78%
Return on Assets TTM:
3.95%
Return on Equity TTM:
5.99%

Company Profile

Haleon plc had its IPO on under the ticker symbol HLNCF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Haleon plc has a staff strength of 24,622 employees.

Stock update

Shares of Haleon plc opened at $4.01 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $4.01 - $4.01, and closed at $4.01.

This is a +0.88% increase from the previous day's closing price.

A total volume of 250 shares were traded at the close of the day’s session.

In the last one week, shares of Haleon plc have increased by 0%.

Haleon plc's Key Ratios

Haleon plc has a market cap of $37.85 billion, indicating a price to book ratio of 1.0525 and a price to sales ratio of 3.4105.

In the last 12-months Haleon plc’s revenue was $11.41 billion with a gross profit of $6.74 billion and an EBITDA of $2.71 billion. The EBITDA ratio measures Haleon plc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Haleon plc’s operating margin was 21.92% while its return on assets stood at 3.95% with a return of equity of 5.99%.

In Q2, Haleon plc’s quarterly earnings growth was a positive 69.8% while revenue growth was a positive 7.5%.

Haleon plc’s PE and PEG Ratio

Forward PE
15.2439
Trailing PE
23.5882
PEG

Its diluted EPS in the last 12-months stands at $0.17 per share while it has a forward price to earnings multiple of 15.2439 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Haleon plc’s profitability.

Haleon plc stock is trading at a EV to sales ratio of 5.4459 and a EV to EBITDA ratio of 33.5164. Its price to sales ratio in the trailing 12-months stood at 3.4105.

Haleon plc stock pays annual dividends of $0.042 per share, indicating a yield of 1.13% and a payout ratio of 0.59%.

Balance sheet and cash flow metrics

Total Assets
$34.16 billion
Total Liabilities
$4.99 billion
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0.59%

Haleon plc ended 2024 with $34.16 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $34.16 billion while shareholder equity stood at $16.45 billion.

Haleon plc ended 2024 with $0 in deferred long-term liabilities, $4.99 billion in other current liabilities, 92000000.00 in common stock, $27.24 billion in retained earnings and $0 in goodwill. Its cash balance stood at $490.00 million and cash and short-term investments were $490.00 million. The company’s total short-term debt was $1,097,000,000 while long-term debt stood at $8.66 billion.

Haleon plc’s total current assets stands at $4.20 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $2.05 billion compared to accounts payable of $3.51 billion and inventory worth $1.50 billion.

In 2024, Haleon plc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Haleon plc paid $0.01 in dividends in 2024.

Other key metrics

Current Trading Price
$4.01
52-Week High
$4.9719
52-Week Low
$0.0021
Analyst Target Price
$

Haleon plc stock is currently trading at $4.01 per share. It touched a 52-week high of $4.9719 and a 52-week low of $4.9719. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $4.09 and 200-day moving average was $3.81 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3940.9% of the company’s stock are held by insiders while 2622.1% are held by institutions.

Frequently Asked Questions About Haleon plc

The stock symbol (also called stock or share ticker) of Haleon plc is HLNCF

The IPO of Haleon plc took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$1024.85
9.7
+0.96%
$242
-0.68
-0.28%
$53.11
0.59
+1.12%
$105.9
-0.1
-0.09%
$29.9
-0.6
-1.97%
$288.65
-25.7
-8.18%
$6.25
0.29
+4.87%
$459.35
-16.8
-3.53%
$21.46
0.42
+2%
Broadcom Inc (AVGO)
$844.52
-14.62
-1.7%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

Address

Building 5, Weybridge, United Kingdom, KT13 0NY